Nabumetone and Psoriasis - a phase IV clinical study of FDA data
Psoriasis is found among people who take Nabumetone, especially for people who are female, 60+ old, have been taking the drug for 10+ years.
The phase IV clinical study analyzes which people take Nabumetone and have Psoriasis. It is created by eHealthMe based on reports of 8,182 people who have side effects when taking Nabumetone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
8,182 people reported to have side effects when taking Nabumetone.
Among them, 110 people (1.34%) have Psoriasis.
What is Nabumetone?
Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 8,594 Nabumetone users for its effectiveness, alternative drugs and more.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,129 drugs and 1,501 conditions by eHealthMe.
Number of Nabumetone and Psoriasis reports submitted per year:
Time on Nabumetone when people have Psoriasis *:
Gender of people who have Psoriasis when taking Nabumetone*:
Age of people who have Psoriasis when taking Nabumetone *:
Common drugs people take besides Nabumetone *:
Common side effects people have besides Psoriasis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Nabumetone and have Psoriasis?Check whether Psoriasis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Alternative drugs to, pros and cons of Nabumetone:
- Nabumetone (8,594 reports)
Psoriasis treatments and more:
- Psoriasis (373,145 reports)
COVID vaccines that are related to Psoriasis:
- Psoriasis in Moderna COVID Vaccine
- Psoriasis in Pfizer BioNTech Covid Vaccine
- Psoriasis in Johnson and Johnson Covid Vaccine
How severe was Psoriasis and when was it recovered:
Expand to all the drugs that have ingredients of nabumetone:
- Psoriasis and drugs with ingredients of nabumetone (131 reports)
Common drugs associated with Psoriasis:
All the drugs that are associated with Psoriasis:
- Psoriasis (2,129 drugs)
Common conditions associated with Psoriasis:
All the conditions that are associated with Psoriasis:
- Psoriasis (1,501 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nabumetone (the active ingredients of Nabumetone) and Nabumetone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.